BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$310M
1-Year Return
6.98%
This Quarter Return
+13.87%
1 Year Return
+6.98%
3 Year Return
+59.66%
5 Year Return
–
10 Year Return
–
AUM
$516M
AUM Growth
+$156M
(+43%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
23.43%
Top 10 Holdings %
Top 10 Hldgs %
65.39%
Holding
139
New
97
Increased
11
Reduced
9
Closed
3
Top Buys
| 1 |
Nuveen Churchill Direct Lending
NCDL
|
+$70.4M |
| 2 |
ProShares UltraPro QQQ
TQQQ
|
+$23.6M |
| 3 |
Conduent
CNDT
|
+$13.6M |
| 4 |
Holley
HLLY
|
+$7.5M |
| 5 |
LanzaTech
LNZA
|
+$5.59M |
Top Sells
| 1 |
Toast
TOST
|
+$8.31M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
+$5.83M |
| 3 |
Viking Therapeutics
VKTX
|
+$5.04M |
| 4 |
Tourmaline Bio
TRML
|
+$4.76M |
| 5 |
Mineralys Therapeutics
MLYS
|
+$3.08M |
Sector Composition
| 1 | Healthcare | 53.49% |
| 2 | Financials | 20.14% |
| 3 | Technology | 17.55% |
| 4 | Consumer Discretionary | 1.46% |
| 5 | Industrials | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sagimet Biosciences
SGMT
$220M
| $4.64M | 0.89% |
1,673,877
| – | – |
|
27
Starwood Property Trust
STWD
$7.52B
| $4.62M | 0.89% |
226,456
| – | – |
|
28
Pyxis Oncology
PYXS
$113M
| $4.13M | 0.8% |
1,126,025
+80,000
| +8% | +$294K |
|
|
CNTA
29
Centessa Pharmaceuticals
CNTA
$2.92B
| $4.08M | 0.79% |
+255,000
| New | +$4.08M |
|
30
Janux Therapeutics
JANX
$1.45B
| $3.63M | 0.7% |
80,000
+40,000
| +100% | +$1.82M |
|
31
AEON Biopharma
AEON
$9.08M
| $3.51M | 0.68% |
+46,406
| New | +$3.51M |
|
|
MREO
32
Mereo BioPharma
MREO
$294M
| $3.48M | 0.67% |
847,809
-50,000
| -6% | -$206K |
|
33
Structure Therapeutics
GPCR
$1.2B
| $2.85M | 0.55% |
65,000
+10,000
| +18% | +$439K |
|
34
Braze
BRZE
$3.35B
| $2.53M | 0.49% |
+78,222
| New | +$2.53M |
|
|
35
Mineralys Therapeutics
MLYS
$2.88B
| $2.38M | 0.46% |
196,132
-254,207
| -56% | -$3.08M |
|
36
ADC Therapeutics
ADCT
$372M
| $2.31M | 0.45% |
733,568
| – | – |
|
37
Immunovant
IMVT
$2.82B
| $2.28M | 0.44% |
80,000
| – | – |
|
38
Blend Labs
BLND
$1.12B
| $1.36M | 0.26% |
361,587
| – | – |
|
39
Payoneer
PAYO
$2.34B
| $1.33M | 0.26% |
+208,203
| New | +$1.33M |
|
|
OMGA
40
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.29M | 0.25% |
1,055,882
| – | – |
|
41
Nu Holdings
NU
$75.8B
| $1.25M | 0.24% |
+91,324
| New | +$1.25M |
|
|
SYRS
42
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.11M | 0.21% |
515,855
+175,000
| +51% | +$376K |
|
43
Enterprise Products Partners
EPD
$68.8B
| $911K | 0.18% |
+31,290
| New | +$911K |
|
44
SHF Holdings
SHFS
$11.9M
| $835K | 0.16% |
+75,896
| New | +$835K |
|
45
GoHealth
GOCO
$79.6M
| $781K | 0.15% |
83,264
| – | – |
|
46
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$574M
| $748K | 0.14% |
+30,000
| New | +$748K |
|
47
enGene Holdings Inc. Warrants
ENGNW
| $728K | 0.14% |
511,177
+460,000
| +899% | +$656K |
|
|
GATE
48
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
| $687K | 0.13% |
+91,429
| New | +$687K |
|
49
Roivant Sciences
ROIV
$9.61B
| $450K | 0.09% |
+39,003
| New | +$450K |
|
|
DM
50
DELISTED
Desktop Metal, Inc.
DM
| $350K | 0.07% |
750,000
| – | – |
|